Cathepsin L

Cathepsin L

Cathepsin L 詳細

Molecule Name
Cathepsin L
分子の別称
CTSL1,MEP,CATL,CTSL
Drug Development Progress
治験薬の数0
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
Cathepsin L1,CATL,CTSL,MEP,EC:3.4.22.15,CTSL1,Major Excreted Protein,Cathepsin L,FLJ31037
バックグランド
Cathepsin L (CTSL1) is also known as major excreted protein (MEP), is a member of the peptidase C1 family, is a dimer composed of disulfide-linked heavy and light chains linked by disulfide bonds. CTSL1 is a lysosomal cysteine proteinase that plays a major role in intracellular protein catabolism. Its substrates include collagen and elastin, as well as alpha-1 protease inhibitor, a major controlling element of neutrophil elastase activity. MEP has been implicated in several pathologic processes, including myofibril necrosis in myopathies and in myocardial ischemia, and in the renal tubular response to proteinuria. CTSL1 is important for the overall degradation of proteins in lysosomes. The specificity of MEP is close to that of papain. As compared to cathepsin B, cathepsin L exhibits higher activity toward protein substrates, but has little activity on Z - Arg – Arg – NHMec, and no peptidyl - dipeptidase activity. Human Cathepsin L activity is greatest under mildly acidic conditions, from pH 4.5 ­ 6.5. The stability of the enzyme decreases at higher pH values

Cathepsin L 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
OlgotrelvirSTI-1558; STI1558ApprovedTexas A&M UniversityOvydso, 奥维宁Mainland ChinaCoronavirus Disease 2019 (COVID-19)Zhejiang Acea Pharmaceutical Co Ltd2025-10-28
Coronavirus Disease 2019 (COVID-19); Pulmonary Disease, Chronic Obstructive
詳細